At Vridam Pharmaceutical Pvt Ltd, we are pleased to share the current status of our manufacturing capabilities, which stand as a testament to our commitment to quality and innovation.
We currently operate two fully functional manufacturing facilities, with an additional third facility proposed for future expansion. Both of our operational plants are WHO-GMP approved, ensuring that we adhere to the highest global standards of pharmaceutical manufacturing.
With our WHO-GMP certifications, we guarantee that all products manufactured at our facilities are produced under stringent quality control measures. This certification reflects our unwavering dedication to maintaining the highest standards of production, assuring our customers of the safety, efficacy, and consistency of every product.
This facility is currently operational and is WHO-GMP approved, ensuring that all production adheres to international quality standards. In the near future, we aim to secure additional global accreditations such as WHO-GENEVA, PIC/S, and EU-GMP, further enhancing our international reputation and trustworthiness.
Our state-of-the-art manufacturing facility is equipped with the latest technology and equipment to ensure high-quality products that meet the standards of the WHO-GMP and PICS guidelines.
Designed and constructed to comply with global standards such as WHO-GMP and PIC/S, ensuring top-notch quality and compliance. A dedicated block to foster innovation, research, and the development of new pharmaceutical formulations.
The new facility will incorporate the latest manufacturing technologies and advanced production lines to increase our capacity to meet global demand. Although final specifications may evolve as the facility progresses, the estimated production capacities are as follows:
